Table 3. Outcome in terms of adverse events at 1-year follow up according to stages of renal function (eGFR with CKD-EPI equation).
All | CKD-EPI ≥80 ml/min/1.73 m2 | CKD-EPI 50–79 ml/min/1.73 m2 | CKD-EPI 30–49 ml/min/1.73 m2 | CKD-EPI <30 ml/min/1.73 m2 | P-value | |
---|---|---|---|---|---|---|
No. of patients | 2398 | 842 | 1133 | 334 | 89 | |
Events n(%) | ||||||
Stroke/TIA/death | 178 (7.9%) | 22 (2.8%) | 73 (7.0%) | 58 (18.5%) | 25 (28.7%) | <0.0001 |
All cause death | 156 (6.5%) | 19 (2.3%) | 60 (5.3%) | 53 (15.9%) | 24 (27.0%) | <0.0001 |
Stroke/TIA | 22 (1.1%) | 3 (0.4%) | 13 (1.3%) | 5 (1.9%) | 1 (1.6%) | 0.0509[*] |
Bleeding | 23 (1.1%) | 6 (0.8%) | 10 (1.0%) | 6 (2.3%) | 1 (1.6%) | 0.1598[*] |
Re-admission for cardiac reason | 592 (28.6%) | 196 (25.5%) | 287 (29.4%) | 91 (34.9%) | 18 (29.5%) | 0.0283 |
Re-admission for non cardiac reason | 268 (12.8%) | 84 (10.8%) | 125 (12.6%) | 40 (15.4%) | 19 (30.6%) | <0.0001 |
Any TE = Stroke, TIA, ACS, Coronary intervention, cardiac arrest, peripheral embolism and pulmonary embolism. *Fisher exact test used for binary variables.